Detalhe da pesquisa
1.
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort.
Mod Rheumatol
; 34(2): 322-328, 2024 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-36786480
2.
3.
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI).
Mod Rheumatol
; 34(2): 297-306, 2024 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37233722
4.
Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA database.
Mod Rheumatol
; 33(5): 899-905, 2023 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36094815
5.
Subjective symptoms contributing to the quality of life of rheumatoid arthritis patients with clinical remission from the IORRA database.
Mod Rheumatol
; 33(3): 496-502, 2023 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35652691
6.
Socioeconomic impact of treatment with biological disease-modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis.
Mod Rheumatol
; 34(1): 27-36, 2023 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36629510
7.
Long-term evaluation of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs.
Mod Rheumatol
; 34(1): 45-49, 2023 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36680420
8.
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate.
Mod Rheumatol
; 34(1): 37-44, 2023 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36680426
9.
Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort.
Mod Rheumatol
; 33(4): 715-722, 2023 Jul 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35920098
10.
Evaluation of RABBIT risk score in Japanese patients with rheumatoid arthritis starting first bDMARDs: a validation study using the IORRA cohort data.
Mod Rheumatol
; 2023 Jul 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37409749
11.
Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: post-hoc subgroup analyses of the Japanese real-world observational "ORIGAMI" study.
Mod Rheumatol
; 2023 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37624029
12.
Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication.
Mod Rheumatol
; 33(1): 36-45, 2023 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35294030
13.
Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication.
Mod Rheumatol
; 33(1): 21-35, 2023 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35297492
14.
Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI study.
Mod Rheumatol
; 33(2): 271-278, 2023 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35389481
15.
Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study.
Rheumatology (Oxford)
; 61(11): 4273-4285, 2022 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35136990
16.
Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics.
Mod Rheumatol
; 32(4): 718-727, 2022 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34918129
17.
Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort.
Mod Rheumatol
; 32(5): 875-884, 2022 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34751783
18.
Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids.
Mod Rheumatol
; 32(3): 522-527, 2022 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34897494
19.
Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort.
Mod Rheumatol
; 32(4): 675-685, 2022 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34918127
20.
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Mod Rheumatol
; 32(2): 313-322, 2022 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-33853484